CURRENT CANCER BIOMARKERS:
Current Cancer Biomarkers is a comprehensive review on the status of biological markers for various types of cancer. It aims to update readers on current developments on the subject. The contents are divided into 5 sections covering a wide range of biomarkers and their diagnostic applications. The r...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
[Place of publication not identified]
BENTHAM Science PUBLISHER,
2023.
|
| Schlagworte: | |
| Online-Zugang: | DE-862 DE-863 |
| Zusammenfassung: | Current Cancer Biomarkers is a comprehensive review on the status of biological markers for various types of cancer. It aims to update readers on current developments on the subject. The contents are divided into 5 sections covering a wide range of biomarkers and their diagnostic applications. The range of tumour biomarkers referenced here gives insights into molecular mechanisms behind cancer, including initiation, development, progression, prognosis, respons. |
| Beschreibung: | 1 online resource |
| ISBN: | 9815079360 9789815079364 |
Internformat
MARC
| LEADER | 00000cam a22000007 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1370200965 | ||
| 003 | OCoLC | ||
| 005 | 20250103110447.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 230225s2023 xx o 000 0 eng d | ||
| 040 | |a YDX |b eng |c YDX |d OCLCO |d OCLCQ |d N$T |d OCLCO |d N$T |d EBLCP |d QGK |d UKKRT | ||
| 019 | |a 1370493171 |a 1463273664 | ||
| 020 | |a 9815079360 |q (electronic bk.) | ||
| 020 | |a 9789815079364 |q (electronic bk.) | ||
| 020 | |z 9789815079371 | ||
| 035 | |a (OCoLC)1370200965 |z (OCoLC)1370493171 |z (OCoLC)1463273664 | ||
| 050 | 4 | |a RC270.3.T84 | |
| 082 | 7 | |a 616.994075 |q OCoLC |2 23/eng/20231120 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a CURRENT CANCER BIOMARKERS |
| 260 | |a [Place of publication not identified] |b BENTHAM Science PUBLISHER, |c 2023. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Part 1: Introduction and Clinically Used Biomarker -- Introduction: Current Status and Future Advances in Cancer Biomarkers -- Farhadul Islam1,* -- INTRODUCTION -- Classical Cancer Biomarker -- Diagnostic Cancer Biomarkers -- Prognostic Cancer Biomarkers -- Predictive Cancer Biomarkers -- Future Cancer Biomarkers -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNKOWLEDGEMENT -- REFERENCES -- Tumour Markers in Clinical Use | |
| 505 | 8 | |a Sujani M. K. Gamage1,2,*, Chamath D. Ranaweera3,4, Tracie T. Cheng1, Sharmin Aktar1,5, Vinod Gopalan1 and Farhadul Islam6 -- INTRODUCTION -- Markers for Colorectal Cancer -- Diagnosis -- Prediction of Prognosis -- Follow up -- Markers for Breast Cancer -- Markers for Thyroid Cancer -- Importance of Thyroglobulin in Differentiated Thyroid Cancer (DTC) -- Surveillance after Thyroidectomy -- Determination of the Requirement of Radioactive Iodine Therapy -- Importance of Calcitonin in Medullary Thyroid Carcinoma (MTC) -- Marker for Hepatocellular Carcinoma -- Screening | |
| 505 | 8 | |a ACKNOWLEDGEMENTS -- REFERENCES -- Part 2: DNA/RNA Biomarkers -- DNA Methylation Landscapes in Cancer and Non-Cancer Cells -- Shaun Stangl1,* and Vinod Gopalan1,* -- INTRODUCTION -- Normal DNA Methylation Location -- Aberrant DNA Methylation in Cancer Genomes -- Methylation-Based Biomarkers -- Bladder Cancer -- Breast Cancer -- Colorectal Cancer -- Lung Cancer -- Ovarian Cancer -- Prostate Cancer -- CONCLUDING REMARKS -- CONSENT OF PUBLICATION: -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Karyotyping and Chromosomal Aberrations in Cancer: Molecular and Diagnostic Biomarkers | |
| 505 | 8 | |a Tracie T. Cheng1,*, Sujani M. K. Gamage1,2, Sharmin Aktar1, Vinod Gopalan1 and Farhadul Islam3,4 -- INTRODUCTION -- CHROMOSOMAL ABERRATIONS AND CANCER -- The Cell Cycle Condensed -- Structural Aberrations and Associated Cancer Markers -- Genetic Biomarkers for Structural Chromosome Aberrations -- DNA Damage Checkpoint -- Replication Fork -- DNA Repair -- Characteristic Aneuploidy as a Cancer Marker and Its Associated Genes -- The Centrosome and the Centromere -- The Kinetochore-Microtubule Complex -- The Spindle Assembly Checkpoint -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION | |
| 520 | |a Current Cancer Biomarkers is a comprehensive review on the status of biological markers for various types of cancer. It aims to update readers on current developments on the subject. The contents are divided into 5 sections covering a wide range of biomarkers and their diagnostic applications. The range of tumour biomarkers referenced here gives insights into molecular mechanisms behind cancer, including initiation, development, progression, prognosis, respons. | ||
| 650 | 0 | |a Tumor markers |x Diagnostic use. |0 http://id.loc.gov/authorities/subjects/sh93001021 | |
| 650 | 0 | |a Cancer |x Diagnosis. |0 http://id.loc.gov/authorities/subjects/sh85019501 | |
| 650 | 6 | |a Marqueurs tumoraux |x Utilisation diagnostique. | |
| 650 | 6 | |a Cancer |x Diagnostic. | |
| 653 | |a Oncology | ||
| 653 | |a Medical | ||
| 700 | 1 | |a Islam, Farhadul. | |
| 776 | 0 | 8 | |i Print version: |a Islam, Farhadul |t Current Cancer Biomarkers |d Ottawa : Bentham Science Publishers,c2023 |z 9789815079371 |
| 966 | 4 | 0 | |l DE-862 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3554224 |3 Volltext |
| 966 | 4 | 0 | |l DE-863 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3554224 |3 Volltext |
| 936 | |a BATCHLOAD | ||
| 938 | |a Kortext |b KTXT |n 2306555 | ||
| 938 | |a YBP Library Services |b YANK |n 304630848 | ||
| 938 | |a EBSCOhost |b EBSC |n 3554224 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL30377305 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-862 | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1370200965 |
|---|---|
| _version_ | 1829095378743459840 |
| adam_text | |
| any_adam_object | |
| author2 | Islam, Farhadul |
| author2_role | |
| author2_variant | f i fi |
| author_facet | Islam, Farhadul |
| author_sort | Islam, Farhadul |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC270 |
| callnumber-raw | RC270.3.T84 |
| callnumber-search | RC270.3.T84 |
| callnumber-sort | RC 3270.3 T84 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Part 1: Introduction and Clinically Used Biomarker -- Introduction: Current Status and Future Advances in Cancer Biomarkers -- Farhadul Islam1,* -- INTRODUCTION -- Classical Cancer Biomarker -- Diagnostic Cancer Biomarkers -- Prognostic Cancer Biomarkers -- Predictive Cancer Biomarkers -- Future Cancer Biomarkers -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNKOWLEDGEMENT -- REFERENCES -- Tumour Markers in Clinical Use Sujani M. K. Gamage1,2,*, Chamath D. Ranaweera3,4, Tracie T. Cheng1, Sharmin Aktar1,5, Vinod Gopalan1 and Farhadul Islam6 -- INTRODUCTION -- Markers for Colorectal Cancer -- Diagnosis -- Prediction of Prognosis -- Follow up -- Markers for Breast Cancer -- Markers for Thyroid Cancer -- Importance of Thyroglobulin in Differentiated Thyroid Cancer (DTC) -- Surveillance after Thyroidectomy -- Determination of the Requirement of Radioactive Iodine Therapy -- Importance of Calcitonin in Medullary Thyroid Carcinoma (MTC) -- Marker for Hepatocellular Carcinoma -- Screening ACKNOWLEDGEMENTS -- REFERENCES -- Part 2: DNA/RNA Biomarkers -- DNA Methylation Landscapes in Cancer and Non-Cancer Cells -- Shaun Stangl1,* and Vinod Gopalan1,* -- INTRODUCTION -- Normal DNA Methylation Location -- Aberrant DNA Methylation in Cancer Genomes -- Methylation-Based Biomarkers -- Bladder Cancer -- Breast Cancer -- Colorectal Cancer -- Lung Cancer -- Ovarian Cancer -- Prostate Cancer -- CONCLUDING REMARKS -- CONSENT OF PUBLICATION: -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Karyotyping and Chromosomal Aberrations in Cancer: Molecular and Diagnostic Biomarkers Tracie T. Cheng1,*, Sujani M. K. Gamage1,2, Sharmin Aktar1, Vinod Gopalan1 and Farhadul Islam3,4 -- INTRODUCTION -- CHROMOSOMAL ABERRATIONS AND CANCER -- The Cell Cycle Condensed -- Structural Aberrations and Associated Cancer Markers -- Genetic Biomarkers for Structural Chromosome Aberrations -- DNA Damage Checkpoint -- Replication Fork -- DNA Repair -- Characteristic Aneuploidy as a Cancer Marker and Its Associated Genes -- The Centrosome and the Centromere -- The Kinetochore-Microtubule Complex -- The Spindle Assembly Checkpoint -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION |
| ctrlnum | (OCoLC)1370200965 |
| dewey-full | 616.994075 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994075 |
| dewey-search | 616.994075 |
| dewey-sort | 3616.994075 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04628cam a22005177 4500</leader><controlfield tag="001">ZDB-4-EBA-on1370200965</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20250103110447.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230225s2023 xx o 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">YDX</subfield><subfield code="b">eng</subfield><subfield code="c">YDX</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCO</subfield><subfield code="d">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">QGK</subfield><subfield code="d">UKKRT</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1370493171</subfield><subfield code="a">1463273664</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9815079360</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789815079364</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9789815079371</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1370200965</subfield><subfield code="z">(OCoLC)1370493171</subfield><subfield code="z">(OCoLC)1463273664</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC270.3.T84</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.994075</subfield><subfield code="q">OCoLC</subfield><subfield code="2">23/eng/20231120</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">CURRENT CANCER BIOMARKERS</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">[Place of publication not identified]</subfield><subfield code="b">BENTHAM Science PUBLISHER,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Part 1: Introduction and Clinically Used Biomarker -- Introduction: Current Status and Future Advances in Cancer Biomarkers -- Farhadul Islam1,* -- INTRODUCTION -- Classical Cancer Biomarker -- Diagnostic Cancer Biomarkers -- Prognostic Cancer Biomarkers -- Predictive Cancer Biomarkers -- Future Cancer Biomarkers -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNKOWLEDGEMENT -- REFERENCES -- Tumour Markers in Clinical Use</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Sujani M. K. Gamage1,2,*, Chamath D. Ranaweera3,4, Tracie T. Cheng1, Sharmin Aktar1,5, Vinod Gopalan1 and Farhadul Islam6 -- INTRODUCTION -- Markers for Colorectal Cancer -- Diagnosis -- Prediction of Prognosis -- Follow up -- Markers for Breast Cancer -- Markers for Thyroid Cancer -- Importance of Thyroglobulin in Differentiated Thyroid Cancer (DTC) -- Surveillance after Thyroidectomy -- Determination of the Requirement of Radioactive Iodine Therapy -- Importance of Calcitonin in Medullary Thyroid Carcinoma (MTC) -- Marker for Hepatocellular Carcinoma -- Screening</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">ACKNOWLEDGEMENTS -- REFERENCES -- Part 2: DNA/RNA Biomarkers -- DNA Methylation Landscapes in Cancer and Non-Cancer Cells -- Shaun Stangl1,* and Vinod Gopalan1,* -- INTRODUCTION -- Normal DNA Methylation Location -- Aberrant DNA Methylation in Cancer Genomes -- Methylation-Based Biomarkers -- Bladder Cancer -- Breast Cancer -- Colorectal Cancer -- Lung Cancer -- Ovarian Cancer -- Prostate Cancer -- CONCLUDING REMARKS -- CONSENT OF PUBLICATION: -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Karyotyping and Chromosomal Aberrations in Cancer: Molecular and Diagnostic Biomarkers</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Tracie T. Cheng1,*, Sujani M. K. Gamage1,2, Sharmin Aktar1, Vinod Gopalan1 and Farhadul Islam3,4 -- INTRODUCTION -- CHROMOSOMAL ABERRATIONS AND CANCER -- The Cell Cycle Condensed -- Structural Aberrations and Associated Cancer Markers -- Genetic Biomarkers for Structural Chromosome Aberrations -- DNA Damage Checkpoint -- Replication Fork -- DNA Repair -- Characteristic Aneuploidy as a Cancer Marker and Its Associated Genes -- The Centrosome and the Centromere -- The Kinetochore-Microtubule Complex -- The Spindle Assembly Checkpoint -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Current Cancer Biomarkers is a comprehensive review on the status of biological markers for various types of cancer. It aims to update readers on current developments on the subject. The contents are divided into 5 sections covering a wide range of biomarkers and their diagnostic applications. The range of tumour biomarkers referenced here gives insights into molecular mechanisms behind cancer, including initiation, development, progression, prognosis, respons.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tumor markers</subfield><subfield code="x">Diagnostic use.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh93001021</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Diagnosis.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85019501</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Marqueurs tumoraux</subfield><subfield code="x">Utilisation diagnostique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Diagnostic.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medical</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Islam, Farhadul.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Islam, Farhadul</subfield><subfield code="t">Current Cancer Biomarkers</subfield><subfield code="d">Ottawa : Bentham Science Publishers,c2023</subfield><subfield code="z">9789815079371</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3554224</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3554224</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="936" ind1=" " ind2=" "><subfield code="a">BATCHLOAD</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Kortext</subfield><subfield code="b">KTXT</subfield><subfield code="n">2306555</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">304630848</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3554224</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL30377305</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1370200965 |
| illustrated | Not Illustrated |
| indexdate | 2025-04-11T08:48:04Z |
| institution | BVB |
| isbn | 9815079360 9789815079364 |
| language | English |
| oclc_num | 1370200965 |
| open_access_boolean | |
| owner | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | BENTHAM Science PUBLISHER, |
| record_format | marc |
| spelling | CURRENT CANCER BIOMARKERS [Place of publication not identified] BENTHAM Science PUBLISHER, 2023. 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Part 1: Introduction and Clinically Used Biomarker -- Introduction: Current Status and Future Advances in Cancer Biomarkers -- Farhadul Islam1,* -- INTRODUCTION -- Classical Cancer Biomarker -- Diagnostic Cancer Biomarkers -- Prognostic Cancer Biomarkers -- Predictive Cancer Biomarkers -- Future Cancer Biomarkers -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNKOWLEDGEMENT -- REFERENCES -- Tumour Markers in Clinical Use Sujani M. K. Gamage1,2,*, Chamath D. Ranaweera3,4, Tracie T. Cheng1, Sharmin Aktar1,5, Vinod Gopalan1 and Farhadul Islam6 -- INTRODUCTION -- Markers for Colorectal Cancer -- Diagnosis -- Prediction of Prognosis -- Follow up -- Markers for Breast Cancer -- Markers for Thyroid Cancer -- Importance of Thyroglobulin in Differentiated Thyroid Cancer (DTC) -- Surveillance after Thyroidectomy -- Determination of the Requirement of Radioactive Iodine Therapy -- Importance of Calcitonin in Medullary Thyroid Carcinoma (MTC) -- Marker for Hepatocellular Carcinoma -- Screening ACKNOWLEDGEMENTS -- REFERENCES -- Part 2: DNA/RNA Biomarkers -- DNA Methylation Landscapes in Cancer and Non-Cancer Cells -- Shaun Stangl1,* and Vinod Gopalan1,* -- INTRODUCTION -- Normal DNA Methylation Location -- Aberrant DNA Methylation in Cancer Genomes -- Methylation-Based Biomarkers -- Bladder Cancer -- Breast Cancer -- Colorectal Cancer -- Lung Cancer -- Ovarian Cancer -- Prostate Cancer -- CONCLUDING REMARKS -- CONSENT OF PUBLICATION: -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Karyotyping and Chromosomal Aberrations in Cancer: Molecular and Diagnostic Biomarkers Tracie T. Cheng1,*, Sujani M. K. Gamage1,2, Sharmin Aktar1, Vinod Gopalan1 and Farhadul Islam3,4 -- INTRODUCTION -- CHROMOSOMAL ABERRATIONS AND CANCER -- The Cell Cycle Condensed -- Structural Aberrations and Associated Cancer Markers -- Genetic Biomarkers for Structural Chromosome Aberrations -- DNA Damage Checkpoint -- Replication Fork -- DNA Repair -- Characteristic Aneuploidy as a Cancer Marker and Its Associated Genes -- The Centrosome and the Centromere -- The Kinetochore-Microtubule Complex -- The Spindle Assembly Checkpoint -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION Current Cancer Biomarkers is a comprehensive review on the status of biological markers for various types of cancer. It aims to update readers on current developments on the subject. The contents are divided into 5 sections covering a wide range of biomarkers and their diagnostic applications. The range of tumour biomarkers referenced here gives insights into molecular mechanisms behind cancer, including initiation, development, progression, prognosis, respons. Tumor markers Diagnostic use. http://id.loc.gov/authorities/subjects/sh93001021 Cancer Diagnosis. http://id.loc.gov/authorities/subjects/sh85019501 Marqueurs tumoraux Utilisation diagnostique. Cancer Diagnostic. Oncology Medical Islam, Farhadul. Print version: Islam, Farhadul Current Cancer Biomarkers Ottawa : Bentham Science Publishers,c2023 9789815079371 |
| spellingShingle | CURRENT CANCER BIOMARKERS Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Part 1: Introduction and Clinically Used Biomarker -- Introduction: Current Status and Future Advances in Cancer Biomarkers -- Farhadul Islam1,* -- INTRODUCTION -- Classical Cancer Biomarker -- Diagnostic Cancer Biomarkers -- Prognostic Cancer Biomarkers -- Predictive Cancer Biomarkers -- Future Cancer Biomarkers -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNKOWLEDGEMENT -- REFERENCES -- Tumour Markers in Clinical Use Sujani M. K. Gamage1,2,*, Chamath D. Ranaweera3,4, Tracie T. Cheng1, Sharmin Aktar1,5, Vinod Gopalan1 and Farhadul Islam6 -- INTRODUCTION -- Markers for Colorectal Cancer -- Diagnosis -- Prediction of Prognosis -- Follow up -- Markers for Breast Cancer -- Markers for Thyroid Cancer -- Importance of Thyroglobulin in Differentiated Thyroid Cancer (DTC) -- Surveillance after Thyroidectomy -- Determination of the Requirement of Radioactive Iodine Therapy -- Importance of Calcitonin in Medullary Thyroid Carcinoma (MTC) -- Marker for Hepatocellular Carcinoma -- Screening ACKNOWLEDGEMENTS -- REFERENCES -- Part 2: DNA/RNA Biomarkers -- DNA Methylation Landscapes in Cancer and Non-Cancer Cells -- Shaun Stangl1,* and Vinod Gopalan1,* -- INTRODUCTION -- Normal DNA Methylation Location -- Aberrant DNA Methylation in Cancer Genomes -- Methylation-Based Biomarkers -- Bladder Cancer -- Breast Cancer -- Colorectal Cancer -- Lung Cancer -- Ovarian Cancer -- Prostate Cancer -- CONCLUDING REMARKS -- CONSENT OF PUBLICATION: -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Karyotyping and Chromosomal Aberrations in Cancer: Molecular and Diagnostic Biomarkers Tracie T. Cheng1,*, Sujani M. K. Gamage1,2, Sharmin Aktar1, Vinod Gopalan1 and Farhadul Islam3,4 -- INTRODUCTION -- CHROMOSOMAL ABERRATIONS AND CANCER -- The Cell Cycle Condensed -- Structural Aberrations and Associated Cancer Markers -- Genetic Biomarkers for Structural Chromosome Aberrations -- DNA Damage Checkpoint -- Replication Fork -- DNA Repair -- Characteristic Aneuploidy as a Cancer Marker and Its Associated Genes -- The Centrosome and the Centromere -- The Kinetochore-Microtubule Complex -- The Spindle Assembly Checkpoint -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION Tumor markers Diagnostic use. http://id.loc.gov/authorities/subjects/sh93001021 Cancer Diagnosis. http://id.loc.gov/authorities/subjects/sh85019501 Marqueurs tumoraux Utilisation diagnostique. Cancer Diagnostic. |
| subject_GND | http://id.loc.gov/authorities/subjects/sh93001021 http://id.loc.gov/authorities/subjects/sh85019501 |
| title | CURRENT CANCER BIOMARKERS |
| title_auth | CURRENT CANCER BIOMARKERS |
| title_exact_search | CURRENT CANCER BIOMARKERS |
| title_full | CURRENT CANCER BIOMARKERS |
| title_fullStr | CURRENT CANCER BIOMARKERS |
| title_full_unstemmed | CURRENT CANCER BIOMARKERS |
| title_short | CURRENT CANCER BIOMARKERS |
| title_sort | current cancer biomarkers |
| topic | Tumor markers Diagnostic use. http://id.loc.gov/authorities/subjects/sh93001021 Cancer Diagnosis. http://id.loc.gov/authorities/subjects/sh85019501 Marqueurs tumoraux Utilisation diagnostique. Cancer Diagnostic. |
| topic_facet | Tumor markers Diagnostic use. Cancer Diagnosis. Marqueurs tumoraux Utilisation diagnostique. Cancer Diagnostic. |
| work_keys_str_mv | AT islamfarhadul currentcancerbiomarkers |